Compare PCVX & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | AFRM |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 21.3B |
| IPO Year | 2020 | 2021 |
| Metric | PCVX | AFRM |
|---|---|---|
| Price | $46.11 | $74.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 28 |
| Target Price | ★ $101.67 | $85.26 |
| AVG Volume (30 Days) | 1.4M | ★ 4.8M |
| Earning Date | 11-04-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.67 |
| Revenue | N/A | ★ $3,459,270,000.00 |
| Revenue This Year | N/A | $28.71 |
| Revenue Next Year | N/A | $24.92 |
| P/E Ratio | ★ N/A | $113.41 |
| Revenue Growth | N/A | ★ 37.01 |
| 52 Week Low | $27.66 | $30.90 |
| 52 Week High | $93.77 | $100.00 |
| Indicator | PCVX | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 51.14 | 54.82 |
| Support Level | $42.40 | $74.48 |
| Resistance Level | $48.65 | $76.49 |
| Average True Range (ATR) | 1.49 | 3.23 |
| MACD | 0.02 | 0.40 |
| Stochastic Oscillator | 59.21 | 70.17 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.